NCT02743325

Brief Summary

Supraventricular tachycardia ablations of the Conformité Européenne (CE)-certified (since 2013) CartoUnivuTM module (Biosense Webster, Diamond Bar, USA) allows a seamless combination of a fluoro image and Carto® 3 System maps into a single view. This helps to reduce fluoroscopy levels and reduce exposure time for physicians, staff and patients to as low as reasonably achievable. The UnivuTM technology will be compared in a randomized manner to the conventional radiofrequency Ablation.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2016

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 15, 2016

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 19, 2016

Completed
6 days until next milestone

Study Start

First participant enrolled

April 25, 2016

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2018

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

September 4, 2020

Status Verified

September 1, 2020

Enrollment Period

2.1 years

First QC Date

March 15, 2016

Last Update Submit

September 2, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • recurrence of arrhythmia documented by ECGs

    Documentation by ECG,7-day-holter ECG, symptoms description by the patient

    within 90 days after the ablation procedure

Secondary Outcomes (4)

  • total fluoroscopy time in minutes

    during the ablation procedure

  • total radiation exposure in gy

    during the ablation procedure

  • Duration of Ablation procedure in minutes

    skin to skin of the ablation procedure

  • Composite adverse events

    within the first 30 days post ablation procedure

Study Arms (2)

ALARA protocol

ACTIVE COMPARATOR

SVT ablation by ALARA protocol

Procedure: SVT ablation by ALARA protocol

current treatment

ACTIVE COMPARATOR

SVT ablation by conventional protocol

Procedure: SVT ablation by conventional protocol

Interventions

Catheter ablation is a procedure that uses radiofrequency energy (similar to microwave heat) to destroy a small area of heart tissue that is causing arrhythmias. Destroying this tissue helps restore your heart's regular rhythm. The usage of CartoUnivuTM allows a seamless combination of a fluoro image and Carto® 3 System maps into a single view.

Also known as: radiofrequency ablation by ALARA protocol
ALARA protocol

Catheter ablation is a procedure that uses radiofrequency energy (similar to microwave heat) to destroy a small area of heart tissue that is causing arrhythmias. Destroying this tissue helps restore your heart's regular rhythm. The convention Ablation procedure works without a 3D navigation System.

Also known as: radiofrequency ablation by conventional protocol
current treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with symptomatic SVT undergoing first SVT ablation procedure (and no prior history of cardiac surgery
  • Structurally normal heart (no major cardiac defects)

You may not qualify if:

  • Previous ablation for SVT (or cardiac surgery)
  • Contra-indications to catheter ablation therapy
  • Congenital heart disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Richard Kobza, PD Dr. med.

    Luzerner Kantonsspital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
PD Dr. med.

Study Record Dates

First Submitted

March 15, 2016

First Posted

April 19, 2016

Study Start

April 25, 2016

Primary Completion

June 1, 2018

Study Completion

December 1, 2018

Last Updated

September 4, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share